(R,S)-Nicotine Synthesis via Segmented Ester Reaction
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for producing nicotine are costly and result in impure nicotine contaminated with carcinogenic compounds from tobacco, making it difficult to achieve commercially viable, high-purity nicotine on an industrial scale.
Innovation Solution
A method involving the reaction of nicotinate ester with N-vinyl-2-pyrrolidinone in the presence of a base and solvent, followed by acid treatment and reduction steps, to synthesize (R,S)-nicotine, achieving purity greater than 99.5% and avoiding tobacco-derived contaminants.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Quantity of substance
If nicotine is extracted from tobacco plant using kerosene solvent, then nicotine can be obtained, but the extracted nicotine contains carcinogenic contaminants and cannot be purified to high purity
Solution Approach 1:
The synthesis is divided into multiple discrete steps: (1) reaction of nicotinate ester with N-vinyl-2-pyrrolidinone to form intermediate, (2) acid treatment to generate myosamine, (3) reduction of myosamine to nornicotine, and (4) methylation of nornicotine to yield final nicotine product. This segmentation allows each step to be optimized for purity and contaminants can be removed between steps.
Solution Approach 2:
The patent removes harmful contaminants by extracting them away from the nicotine synthesis pathway. By using synthetic precursors (nicotinate ester) rather than tobacco extract, and implementing multiple purification steps including acid treatment and base extraction, the process extracts and eliminates carcinogenic compounds while retaining the desired nicotine product.
2Manufacturing precision
If synthetic methods are used to prepare pure nicotine, then nicotine purity can be improved, but the manufacturing cost becomes prohibitively high on industrial scale
Solution Approach 1:
The patent optimizes reaction parameters including using readily available starting materials (nicotinate ester and N-vinyl-2-pyrrolidinone), controlling pH through sequential acid and base treatment, and optimizing reduction conditions. These parameter changes maintain high purity while reducing manufacturing costs compared to previous synthetic methods.
Solution Approach 2:
The patent employs inexpensive, readily available chemical reagents and starting materials that can be obtained at low cost at industrial scale. The use of common chemicals like bases and acids for pH adjustment, rather than expensive specialized reagents, significantly reduces manufacturing costs while maintaining product purity.
3Manufacturing precision
If multiple purification steps are implemented to remove contaminants, then nicotine purity increases, but the process complexity and manufacturing time increase
Solution Approach 1:
The patent combines multiple functions into integrated steps: the acid treatment step simultaneously serves to (1) hydrolyze the intermediate, (2) extract contaminants into the aqueous layer, and (3) prepare the product for the next reduction step. This merging reduces the number of separate unit operations and simplifies the overall process while maintaining high purity.
Solution Approach 2:
The synthesis proceeds through continuous sequential steps without interruption: ester reaction → acid treatment → base extraction → reduction → methylation. Each step flows directly into the next with the product of one step serving as the substrate for the following step, maintaining continuous useful action and minimizing downtime or intermediate storage.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This method provides a cost-effective, industrially scalable synthesis of pharmaceutically pure (R,S)-nicotine, meeting USP grade standards and offering favorable pricing by using readily available starting materials, thus overcoming the challenges of previous methods.
Implementation Method 1
reacting a nicotinate ester with N-vinyl-2-pyrrolidinone in the presence of a base and a solvent to form a first mixture
Implementation Method 2
combining the first mixture with an acid to form a second mixture comprising an aqueous layer, separating the aqueous layer from second mixture
Implementation Method 3
reducing myosmine to nornicotine using a reducing agent
Data Source
AI summary
A method of preparing (R,S)-nicotine, comprising reacting a nicotinate ester with N-vinyl-2-pyrrolidinone in the presence of a base and a solvent to form a first mixture, combining the first mixture with an acid to form a second mixture comprising an aqueous layer, separating the aqueous layer from second mixture, combining the separated aqueous layer with an acid to form a third mixture, combining the third mixture with a base to form a fourth mixture comprising myosamine, reducing myosamine to nornicotine using a reducing agent, and methylating the nornicotine to yield R,S-nicotine.